Understanding the signaling and transmission of visceral nociceptive events
- 7 September 2004
- journal article
- review article
- Published by Wiley in Journal of Neurobiology
- Vol. 61 (1) , 45-54
- https://doi.org/10.1002/neu.20084
Abstract
Visceral pain can be considered as part of the defense reactions of the body against harmful stimuli, particularly of those that impinge on the mucosal lining of hollow organs. It is a problem of considerable clinical relevance, and its neurobiological mechanisms differ from those of somatic nociceptive or neuropathic pain. Much progress had been made in recent years in the understanding of the functional properties of the visceral nociceptors that trigger pain states, their molecular mechanisms of activation and sensitization and on their central actions. Some molecular targets have been identified as key players in the activation and sensitization of visceral nociceptors, notably ASICs, TTX‐resistant Na channels and the TRPV1 receptor. Some nonneural elements of visceral organs, such as the urothelium have been shown to play active roles in the transduction of visceral sensory events by mechanisms involving ATP release by the urothelial cells. Certain well‐known neurotransmitters, such as the tachykinin family of neuropeptides, likely play an important role in the peripheral and central activation of visceral nociceptive afferents and in the generation of visceral hyperalgesia. This article reviews current evidence on the mechanisms of activation and sensitization of visceral nociceptive afferents and on their role in the triggering and maintenance of clinically relevant visceral pain states. © 2004 Wiley Periodicals, Inc. J Neurobiol 61: 45–54, 2004Keywords
This publication has 76 references indexed in Scilit:
- Vanilloid receptors take a TRP beyond the sensory afferent☆Pain, 2003
- Distribution of the vanilloid receptor (VR1) in the gastrointestinal tractJournal of Comparative Neurology, 2003
- Spontaneous muscle twitches during sleep guide spinal self-organizationNature, 2003
- N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic PainThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neuronsNature Neuroscience, 2001
- The Vanilloid Receptor: A Molecular Gateway to the Pain PathwayAnnual Review of Neuroscience, 2001
- Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin ReceptorScience, 2000
- Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in ratsBritish Journal of Pharmacology, 2000
- Tachykinins in the gut. Part I. Expression, release and motor functionPharmacology & Therapeutics, 1997
- A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neuronsNature, 1996